NCT06809933 Exercise and Movement to Enhance Resiliency in Cancer Patients
| NCT ID | NCT06809933 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Gynecologic Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2031-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-03-24 with a primary completion date of 2031-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older. 2. Newly diagnosed with a gynecological cancer (including ovarian tubal or peritoneal, uterine, cervical, vaginal, vulvar, and/or gestational trophoblastic neoplasia) and currently undergoing treatment chemotherapy, surgery, etc.). 3. Able to understand study procedures and to comply with study procedures for the entire length of the study. 4. Ability to understand a written informed consent document, and the willingness to sign it. 5. Eastern Cooperative Oncology Group (ECOG) status \< 4. 6. Willingness to participate and wear an activity tracker (FitBit). 7. Planning to start systemic treatment or currently receiving Cycle 1 of systemic treatment. Exclusion Criteria: 1. Medically ineligible or contraindications to exercise as determined by their oncologist; or contradiction to any other study-related procedure or assessment. 2. Cognitive or visual impairments that would limit participant's ability to utilize and interact with the DHT platform. Note: If a visually impaired participant has a caregiver who can help them use the DHT platform, the participant will not be excluded. 3. Existing performance of excessive physical activity (\>210 minutes per week of moderate to vigorous intensity exercise at baseline). 4. Existing enrollment in an exercise program or physical therapy program. 5. Inability to speak and read English.
Contact & Investigator
Stephanie Cham, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06809933 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06809933 currently recruiting?
Yes, NCT06809933 is actively recruiting participants. Contact the research team at EMPOWER@ucsf.edu for enrollment information.
Where is the NCT06809933 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06809933 clinical trial?
NCT06809933 is sponsored by University of California, San Francisco. The principal investigator is Stephanie Cham, MD at University of California, San Francisco. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.